Amy Jacob

This is the first FDA-approved therapy specific to this form of vasculitis.

NIAID Director Anthony Fauci, MD is globally renowned for immunology research.

John Stone, MD, Massachusetts General Hospital, discussed study results and fear surrounding giant cell arteritis.

Nancy Lane, MD, discussed her team's study on abaloparatide, a new preparation of a hormone, and how it can stimulate bone formation.

While it has been known for some time that psoriasis patients are at increased risk of developing cardiovascular disease and other comorbidities, new research has shown that these patients also have a higher risk of developing aortic aneurysms.

Many psoriasis patients wish they were better informed of the significant impact their skin condition would have on their physical and mental health, according to results from Psoriasis in America 2016, a Health Union national survey.

Patients afflicted with severe psoriasis may be at higher risk for chronic pancreatitis (CP).

The gut microbiome has previously been considered a therapeutic target for the immune system, and new research suggests the microbiome’s composition can hold the key to managing psoriasis.

Novartis conducted a global survey of 8,338 patients with moderate-to-severe psoriasis across 31 countries to assess patients’ perceptions of what constitutes “clear skin.â€

In patients diagnosed with psoriasis, disease severity has been strongly associated with developing a higher risk of comorbidities affecting the kidney, liver, and pancreas.

Patients suffering from psoriasis are at increased risk of developing serious infections.

After the FDA’s March approval of ixekizumab (Taltz/ Eli Lilly and Company), researchers recently confirmed the psoriasis treatment was beneficial even after 60 weeks.

Biologic drug secukinumab (Cosentyx/Novartis), already FDA approved in January 2015 to treat chronic plaque psoriasis, has now been approved for two new indications: the treatment of active ankylosing spondylitis (AS) and active psoriatic arthritis (PsA).

Patient with autoimmune diseases, like psoriasis, and infected with herpes zoster – commonly known as shingles – have a 50% higher risk of suffering a stroke.

Researchers found that adding kunzea oil to topical psoriasis treatments with liquor carbonis detergens (LCD) and salicylic acid did not improve the irritating skin condition.

Researchers have identified a set of rules that determine which molecules can trigger immune system vulnerability to common autoimmune disorders like lupus and psoriasis.